Connecting Investors, Business Leaders, and Strategics to Accelerate Radiopharmaceuticals Innovation

Join us for an exclusive gathering of senior-level investors, corporate executives, entrepreneurs, and strategics at the Inaugural Radiopharmaceuticals Venture, Innovation & Partnering Summit, October 1, 2025, in Boston, MA. Connect with future partners and investors at intimate networking sessions; gain strategic insights on funding activities, business development, and innovation strategies in radiopharmaceuticals from industry-led panels; hear candid perspectives from radiopharma thought leaders during dynamic fireside chats; and catch up on innovative technologies presented by emerging companies. Building on the successful launch of the Oncology VIP Summit in 2024, this boutique event is positioned as the premier meeting place for key radiopharmaceuticals stakeholders to foster meaningful connections, acquire valuable strategic insights, and drive innovation and collaboration. The meeting is co-located with Second Annual Oncology Venture, Innovation & Partnering Summit, September 29-30.

EVENT FEATURES:

Network with CEOs, pharma thought leaders, investors, and strategics at exclusive networking events
Gather actionable insights from radiopharmaceuticals KOLs during engaging panel discussions
Strategize for commercial success and learn from radiopharma executives at fireside chats
Brainstorm most timely topics and meet future partners and investors at targeted roundtables
Learn the latest innovations in new company and technology showcases
Attend co-located Oncology VIP Summit
Join the annual meeting and accelerate radiopharmaceuticals innovation!

AGENDA

SPEAKERS

DOWNLOADS

2025 Agenda Topics Include

Future opportunities in oncology investments and strategies to de-risk
Future investment opportunities in radiopharmaceuticals and key learnings from early investments
Understanding and managing risk in radiopharmaceutical development
What conditions need to be met for a radiopharmaceutical to become a blockbuster?
Big pharma perspective on radiopharmaceutical investment, partnering, and M&A
Next-gen targeted radiopharmaceuticals: targets, targeting technologies, and isotopes

Strategic considerations for the choice of radioisotopes
Scalable supply chains for radiopharmaceutical manufacturing
Regulatory and market access challenges
Streamlining radiopharmaceutical clinical trials
Theranostics: imaging and artificial intelligence (AI) for personalized therapy
Unanswered challenges in targeted radiopharmaceuticals: potential for combination therapies, Alpha vs Beta emitters, dosimetry models, immune response, etc.